2,5-bis(1-aziridinyl)-3,6-bis(2-methoxyethoxy)-4-benzoquinone and Histiocytic Sarcoma

2,5-bis(1-aziridinyl)-3,6-bis(2-methoxyethoxy)-4-benzoquinone has been researched along with Histiocytic Sarcoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (100.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Becton, DL; Chaffee, S; Falletta, JM; Friedman, HS; Kinney, TR; Kurtzberg, J	1

Other Studies

1 other study(ies) available for 2,5-bis(1-aziridinyl)-3,6-bis(2-methoxyethoxy)-4-benzoquinone and Histiocytic Sarcoma

Article	Year
Treatment of lymphohistiocytic erythrophagocytosis with VP-16 and aziridinylbenzoquinone. Medical and pediatric oncology, 1987, Volume: 15, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Aziridines; Benzoquinones; Child, Preschool; Cyclohexenes; Cytarabine; Female; Histiocytic Sarcoma; Humans; Hydrocortisone; Infant, Newborn; Male; Methotrexate; Podophyllotoxin; Prednisone; Remission Induction; Thiotepa; Time Factors	1987

Article

Year

Treatment of lymphohistiocytic erythrophagocytosis with VP-16 and aziridinylbenzoquinone.

Medical and pediatric oncology, 1987, Volume: 15, Issue:2

Topics: Antineoplastic Combined Chemotherapy Protocols; Aziridines; Benzoquinones; Child, Preschool; Cyclohexenes; Cytarabine; Female; Histiocytic Sarcoma; Humans; Hydrocortisone; Infant, Newborn; Male; Methotrexate; Podophyllotoxin; Prednisone; Remission Induction; Thiotepa; Time Factors

1987